Back to search
Inflammatory Breast Cancer (IBC)
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Inflammatory Breast Cancer (IBC) trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Inflammatory Breast Cancer (IBC) trials you may qualify forThis trial studies the biospecimen and medical data collection in creating a research tissue registry in patients with inflammatory or invasive breast cancer. C…
This study will prospectively determine the feasibility and oncological safety of sentinel lymph node biopsy (SLNB) after neoadjuvant chemotherapy (NACT) in inf…
This Feasibility study is trying to determine: * If Lymphoscintigraphy (imaging of the lymphatic drainage patterns) is effective in demonstrating the drainage…
The purpose of this study is to test the safety and effectiveness of an investigational drug combination (trastuzumab deruxtecan and durvalumab) to learn whethe…
This phase I/II trial studies the side effect and best dose of neratinib and to see how well it works with paclitaxel and with or without pertuzumab and trastuz…
This research study is studying Ruxolitinib as possible treatment for Inflammatory Breast Cancer (IBC). The Following drugs will be use in combination with Rux…